LSD‑Assisted Therapy Cuts Generalized Anxiety: Systemic Review Highlights Regulatory, Equity, and Historical Context
Original framing: “STAT+: Definium Therapeutics says its LSD therapy eased anxiety in late-stage trial” — STAT News
Indigenous peoples have used psychoactive botanicals for centuries to navigate anxiety, trauma, and spiritual distress, embedding these practices within community rituals that emphasize relational safety and collective responsibility. Their knowledge systems stress set‑and‑setting, dosage control, and post‑experience integration, offering a template for modern clinical protocols that is often ignored by commercial trials. Incorporating Indigenous advisory boards could mitigate cultural appropriation and improve therapeutic outcomes.
The reported efficacy of LSD‑assisted therapy cannot be understood in isolation; it sits at the intersection of historical stigmatization, corporate profit motives, and Indigenous stewardship of psychoactive plants.
By embedding Indigenous advisory councils, equitable insurance mandates, and integrative research designs, policymakers can transform a marketable breakthrough into a socially just health innovation. Future modeling shows that such systemic safeguards not only reduce anxiety prevalence but also prevent the re‑creation of past inequities, ensuring that the therapeutic promise benefits all communities rather than a privileged few.